Charles Schwab Investment Management Inc. Increases Stock Position in Protagonist Therapeutics, Inc. (NASDAQ:PTGX)
Charles Schwab Investment Management Inc. lifted its position in shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free ...
Analysts Mentions Growth Catalysts for Protagonist Therapeutics (PTGX) — Best Biotech Stock for 2025?
We recently published a list of Top 10 Trending Stocks as AI Hype Fades. In this article, we are going to take a look at ...
Protagonist Therapeutics Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2025
Fast Company's annual list of the World's Most Innovative Companies spotlights organizations across various industries that are driving meaningful change through groundbreaking ideas and ...
Is Protagonist Therapeutics, Inc. (PTGX) the Best Healthcare Stock For Long-Term Investment?
We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a ...
J.P. Morgan Reaffirms Their Buy Rating on Protagonist Therapeutics (PTGX)
J.P. Morgan analyst Brian Cheng maintained a Buy rating on Protagonist Therapeutics (PTGX – Research Report) yesterday and set a price target ...